Associated Papers
Characterisation of pharmacogenomic variation in the Shetland and Orkney Isles in Scotland.
Twesigomwe D et al.
Scientific Reports, 2025
The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals.
Wang LY et al.
Innovation (cambridge (mass.)), 2025
PharmVar GeneFocus: CYP4F2.
Zubiaur P et al.
Clinical Pharmacology and Therapeutics, 2024
Cytochrome P450 Family 4F2 and 4F11 Haplotype Mapping and Association with Hepatic Gene Expression and Vitamin K Hydroxylation Activity.
Alade AN et al.
Acs Pharmacology & Translational Science, 2024
Effect of donor GSTM3 rs7483 genetic variant on tacrolimus elimination in the early period after liver transplantation.
Zhang T et al.
Peerj, 2024
Functional Characterization of 29 Cytochrome P450 4F2 Variants Identified in a Population of 8380 Japanese Subjects and Assessment of Arachidonic Acid ω-Hydroxylation.
Sato Y et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2023
The pharmacogenomic landscape of an Indigenous Australian population.
Samarasinghe SR et al.
Frontiers in Pharmacology, 2023
Targeted haplotyping in pharmacogenomics using Oxford Nanopore Technologies' adaptive sampling.
Deserranno K et al.
Frontiers in Pharmacology, 2023
Clinical pharmacogenetic analysis in 5,001 individuals with diagnostic Exome Sequencing data.
Lanillos J et al.
Npj Genomic Medicine, 2022
Case report: Two unique nonsense mutations in HTRA1-related cerebral small vessel disease in a Chinese population and literature review.
Chen W et al.
Frontiers in Neurology, 2022
Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China.
Li D et al.
Bmc Genomic Data, 2021
Combination of Genome-Wide Polymorphisms and Copy Number Variations of Pharmacogenes in Koreans.
Han N et al.
Journal of Personalized Medicine, 2021
Identification of novel CYP4F2 genetic variants exhibiting decreased catalytic activity in the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE).
Kim WY et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids, 2018
CYP4F2 affects phenotypic outcome in adrenoleukodystrophy by modulating the clearance of very long-chain fatty acids.
van Engen CE et al.
Biochimica Et Biophysica Acta, 2016
Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.
Pratt VM et al.
The Journal of Molecular Diagnostics : Jmd, 2016
Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCX.
Fohner AE et al.
Pharmacogenetics and Genomics, 2015
The revised human liver cytochrome P450 "Pie": absolute protein quantification of CYP4F and CYP3A enzymes using targeted quantitative proteomics.
Michaels S et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2014
Genetic polymorphism of cytochrome P450 4F2, vitamin E level and histological response in adults and children with nonalcoholic fatty liver disease who participated in PIVENS and TONIC clinical trials.
Athinarayanan S et al.
Plos One, 2014
Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia.
Flanagan JM et al.
Blood, 2013
Integrating precision medicine in the study and clinical treatment of a severely mentally ill person.
O'Rawe JA et al.
Peerj, 2013
Absence of novel CYP4F2 and VKORC1 coding region DNA variants in patients requiring high warfarin doses.
Burmester JK et al.
Clinical Medicine & Research, 2011
Genes involved in the metabolism of poly-unsaturated fatty-acids (PUFA) and risk for Crohn's disease in children & young adults.
Costea I et al.
Plos One, 2010
Common variants of cytochrome P450 4F2 exhibit altered vitamin E-{omega}-hydroxylase specific activity.
Bardowell SA et al.
The Journal of Nutrition, 2010
Association of a functional cytochrome P450 4F2 haplotype with urinary 20-HETE and hypertension.
Liu H et al.
Journal of the American Society of Nephrology : Jasn, 2008
Functional polymorphism in human CYP4F2 decreases 20-HETE production.
Stec DE et al.
Physiological Genomics, 2007
Japanese single nucleotide polymorphism database for 267 possible drug-related genes.
Iida A et al.
Cancer Science, 2006
[SNP collection, pharmacogenomics, and the future of drug therapy].
Iida A et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy, 2002
906 variations among 27 genes encoding cytochrome P450 (CYP) enzymes and aldehyde dehydrogenases (ALDHs) in the Japanese population.
Saito S et al.
Journal of Human Genetics, 2002